Endometriosis Clinical Trial
— DOROSYOfficial title:
Randomized Phase 2 Trial Comparing Preoperative Dienogest Therapy Followed by Surgery vs. Upfront Surgery to Save Ovarian Reserve in Young Women With Ovarian Endometrioma
Verified date | October 2017 |
Source | Seoul National University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Randomized phase 2 trial comparing preoperative dienogest therapy followed by surgery vs. upfront surgery to save ovarian reserve in young women with ovarian endometrioma
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | March 2018 |
Est. primary completion date | March 2018 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 20 Years to 45 Years |
Eligibility |
Inclusion Criteria: - Unilateral ovarian endometrioma = 5cm or bilateral ovarian endometriomas with any size diagnosed by ultrasonography. - In Patients with previous unilateral salpingo-oophorectomy (USO) - Unilateral ovarian endometrioma with any size is eligible - 20 = Age = 45 and premenopause - Plan to undergo conservative surgery for endometriomas Exclusion Criteria: - Pregnant women or women who were suspected to be pregnant - Women with current venous thromboembolism or history of such diseases - Women with current arterial disease or cardiovascular diseases (e.g. myocardial infarction, cerebrovascular diseases, or ischemic heart diseases) or history of such diseases - Women with current diabetes with vascular lesions or history of such diseases - Women with current severe liver diseases or history of severe liver diseases with abnormal liver function - Women with current liver tumor or history of liver tumor - Women with current or history of sex-hormone dependent malignant tumor or women who were suspected to have a sex-hormone dependent malignant tumor - Women with vaginal bleeding of unknown causes - Women with a history of allergic reaction to elements of DNG - Women with galactose intolerance, Lapp lactase deficiency, glucose-galactose malabsorption - Women whose non-compliance is expected - Lactation (treatment with DNG is not recommended in lactating women due to possible excretion in breast milk) - Any medication that could result in an excessive accumulation, impaired metabolism, or altered excretion of the study drug or might interfere with the conduct of the study or the interpretation of the results |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Seoul National University Bundang Hospital | Seongnam Si | Gyeonggi Do |
Lead Sponsor | Collaborator |
---|---|
Seoul National University Hospital | Ajou University School of Medicine, Asan Medical Center, Ewha Womans University Mokdong Hospital, Korea University Guro Hospital, Kyung Hee University Hospital at Gangdong |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Compare the mean change of serum Anti-Mullerian Hormone (AMH) level | 3 month after surgery | ||
Secondary | Compare the mean change of serum AMH level | 1 month after surgery | ||
Secondary | Compare the trend of mean change of serum AMH level | 1 and 3 month after surgery | ||
Secondary | Compare the mean change of serum AMH level | baseline and after preoperative dienogest/placebo therapy for 3 months | ||
Secondary | Compare the revised American fertility society (AFS) score | At surgery | ||
Secondary | compare the surgical time (minute) | surgical time (minute) | intraoperative | |
Secondary | Brief Pain Inventory (BPI) scores | baseline, 1 month after surgery and 3 month after surgery | ||
Secondary | number of participants with treatment-related adverse events as assessed by CTCAE v4.0 | All adverse events from randomization to postoperative 3 months | ||
Secondary | Mean change of diameter of endometrioma measured by ultrasonography after preoperative dienogest/placebo therapy for 3months | baseline and after preoperative dienogest/placebo therapy for 3 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01931670 -
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
|
Phase 3 | |
Recruiting |
NCT05648669 -
A Study to Evaluate Safety and Efficacy of Elagolix in Patients With Moderate to Severe Endometriosis-Associated Pain
|
Phase 3 | |
Completed |
NCT04081532 -
The Effectiveness of Laparoscopic Treatment of Superficial Endometriosis for Managing Chronic Pelvic Pain
|
N/A | |
Recruiting |
NCT06101303 -
Endometriosis Pain
|
||
Completed |
NCT04665414 -
Diagnosis of Adenomyosis Using Ultrasound, Elastography and MRI
|
||
Completed |
NCT03690765 -
Study of Real Clinical Practice to Evaluate the Effects of Oral Dydrogesterone for Treatment of Confirmed Endometriosis
|
||
Recruiting |
NCT05153512 -
ADOlescent DysmenoRrhea Endometriosis Assessment Magnetic Resonance Imaging (Adodream)
|
||
Active, not recruiting |
NCT04171297 -
Ultrasound Evaluation of the Pelvis in Women With Suspected Endometriosis Scheduled for Laparoscopic Surgery
|
||
Recruiting |
NCT04172272 -
The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures
|
N/A | |
Completed |
NCT04565470 -
Strategies of Self-management of Endometriosis Symptoms
|
||
Completed |
NCT03613298 -
Treatment by HIFU With Focal One® of Posterior Deep Infiltrating Endometriosis Lesions With Intestinal Involvement.
|
N/A | |
Withdrawn |
NCT05568940 -
Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids
|
||
Not yet recruiting |
NCT03464799 -
Does Immunotherapy Have a Role in the Management of Endometriosis?
|
||
Active, not recruiting |
NCT03002870 -
Characteristics of Patient Population With Endometriosis
|
N/A | |
Withdrawn |
NCT03272360 -
Endometriosis Biomarker Discovery Study
|
N/A | |
Completed |
NCT02973854 -
Activation of the Sphingosine-1-phosphate (S1P) to S1P1 Receptor Subtype (S1PR1) Axis in Patients With Endometriosis: Identification of Potential Relevant Biomarkers to Diagnose and Treat
|
||
Recruiting |
NCT02481739 -
Laparoscopic Surgical Management of Endometriosis on Fertility
|
N/A | |
Active, not recruiting |
NCT02754648 -
Three Different Laparoscopic Approaches for Ovarian Endometrioma and the Effect on Ovarian Reserve
|
N/A | |
Completed |
NCT06106932 -
GnRH-a on Angiogenesis of Endometriosis
|
N/A | |
Completed |
NCT02387931 -
Supplementation in Adolescent Girls With Endometriosis
|
Phase 4 |